Abstract:Background Pulmonary perfusion defects have been observed in patients with coronavirus disease 2019 (COVID‐19). Currently, there is a need for further data on non‐contrast‐enhanced MRI in COVID patients. The early identification of heterogeneity in pulmonary perfusion defects among COVID‐19 patients is beneficial for their timely clinical intervention and management. Purpose To investigate the utility of phase‐resolved functional lung (PREFUL) MRI in detecting pulmonary perfusion disturbances in individuals with postacute COVID‐19 syndrome (PACS). Study Type Prospective. Subjects Forty‐four participants (19 females, mean age 64.1 years) with PACS and 44 healthy subjects (19 females, mean age 59.5 years). Moreover, among the 44 patients, there were 19 inpatients and 25 outpatients; 19 were female and 25 were male; 18 with non‐dyspnea and 26 with dyspnea. Field Strength/Sequence 3‐T, two‐dimensional (2D) spoiled gradient‐echo sequence. Assessment Ventilation and perfusion‐weighted maps were extracted from five coronal slices using PREFUL analysis. Subsequently, perfusion defect percentage (QDP), ventilation defect percentage (VDP), and ventilation‐perfusion match healthy (VQM) were calculated based on segmented lung parenchyma ventilation and perfusion‐weighted maps. Additionally, clinical features, including demographic data (such as sex and age) and serum biomarkers (such as D‐dimer levels), were evaluated. Statistical Tests Spearman correlation coefficients to explore relationships between clinical features and QDP, VDP, and VQM. Propensity score matching analysis to reduce the confounding bias between patients with PACS and healthy controls. The Mann–Whitney U tests and Chi‐squared tests to detect differences between groups. Multivariable linear regression analyses to identify factors related to QDP, VDP, and VQM. A P‐value <0.05 was considered statistically significant. Results QDP significantly exceeded that of healthy controls in individuals with PACS (39.8% ± 15.0% vs. 11.0% ± 4.9%) and was significantly higher in inpatients than in outpatients (46.8% ± 17.0% vs. 34.5% ± 10.8%). Moreover, males exhibited pulmonary perfusion defects significantly more frequently than females (43.9% ± 16.8% vs. 34.4% ± 10.2%), and dyspneic participants displayed significantly higher perfusion defects than non‐dyspneic patients (44.8% ± 15.8% vs. 32.6% ± 10.3%). QDP showed a significant positive relationship with age (β = 0.50) and D‐dimer level (β = 0.72). Data Conclusion PREFUL MRI may show pulmonary perfusion defects in patients with PACS. Furthermore, perfusion impairments may be more pronounced in males, inpatients, and dyspneic patients. Evidence Level 2 Technical Efficacy Stage 2

Feasibility, Repeatability, and Correlation to Lung Function of Phase‐Resolved Functional Lung (PREFUL) MRI‐derived Pulmonary Artery Pulse Wave Velocity Measurements

Lung Volume Dependence and Repeatability of Hyperpolarized 129xe MRI Gas Uptake Metrics in Healthy Volunteers and Participants with COPD.

Phase-Resolved Functional Lung (PREFUL)-MRI-derived parameters in evaluating chronic thromboembolic pulmonary disease: a prospective study

Free-breathing 3D phase-resolved functional lung MRI vs breath-hold hyperpolarized 129Xe ventilation MRI in patients with chronic obstructive pulmonary disease and healthy volunteers

Phase-Resolved Functional Lung (PREFUL) MRI to Quantify Ventilation: Feasibility and Physiological Relevance in Severe Asthma

Estimating ventilation correlation coefficients in the lungs using PREFUL‐MRI in chronic obstructive pulmonary disease patients and healthy adults

Comparison of Free‐Breathing 3D Phase‐Resolved Functional Lung (PREFUL) MRI With Dynamic 19F Ventilation MRI in Patients With Obstructive Lung Disease and Healthy Volunteers

Phase‐Resolved Functional Lung (PREFUL) MRI May Reveal Distinct Pulmonary Perfusion Defects in Postacute COVID‐19 Syndrome: Sex, Hospitalization, and Dyspnea Heterogeneity

PREFUL MRI Depicts Dual Bronchodilator Changes in COPD: A Retrospective Analysis of a Randomized Controlled Trial

Influence of echo time on pulmonary ventilation and perfusion derived by phase‐resolved functional lung (PREFUL) MRI using multi‐echo ultrashort echo time acquisition

Phase-resolved MRI for measurement of pulmonary perfusion and ventilation defects in comparison with dynamic contrast-enhanced MRI and 129Xe MRI

Phase-Resolved Functional Lung MRI for Pulmonary Ventilation and Perfusion (V/Q) Assessment

Clinical utility of ventilatory and gas exchange evaluation during low-intensity exercise for risk stratification and prognostication in pulmonary arterial hypertension

Free‐Breathing Functional Pulmonary Proton MRI: A Novel Approach Using Voxel‐Wise Lung Ventilation (VOLVE) Assessment in Healthy Volunteers and Patients With Chronic Obstructive Pulmonary Disease

Three-Dimensional Phase Resolved Functional Lung Magnetic Resonance Imaging

Abstract 11806: CT Measure of Intraparenchymal Vascular Volume in Chronic Obstructive Pulmonary Disease Patients With and Without Pulmonary Hypertension

Influence of gadolinium, field-strength and sequence type on quantified perfusion values in phase-resolved functional lung MRI

Endothelial Function Correlates With Pulmonary Pressures in Subjects With Clinically Suspected Pulmonary Hypertension

O66 CONCORDANCE BETWEEN THE PULSE WAVE VELOCITY ESTIMATED WITH TOTAL ARTERIAL COMPLIANCE AND CAROTID-FEMORAL PULSE WAVE VELOCITY MEASUREMENTS

MR 4D flow-based mean pulmonary arterial pressure tracking in pulmonary hypertension

Doppler echocardiographic evaluation of pulmonary artery pressure in chronic obstructive pulmonary disease. A European multicentre study